Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial
出版年份 2014 全文链接
标题
Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 16, Issue 10, Pages 922-930
出版商
Wiley
发表日期
2014-04-07
DOI
10.1111/dom.12298
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement - Executive Summary
- (2013) Alan Garber et al. Endocrine Practice
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
- (2013) Chantal Mathieu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes
- (2012) T. Heise et al. DIABETES OBESITY & METABOLISM
- Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes
- (2012) T. Heise et al. DIABETES OBESITY & METABOLISM
- Update in the CNS Response to Hypoglycemia
- (2012) Rory J. McCrimmon JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Alan J Garber et al. LANCET
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Simon Heller et al. LANCET
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
- (2012) Ib Jonassen et al. PHARMACEUTICAL RESEARCH
- Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
- (2011) K. I. Birkeland et al. DIABETES CARE
- The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management
- (2011) Meryl Brod et al. VALUE IN HEALTH
- Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial
- (2009) Simon Heller et al. CLINICAL THERAPEUTICS
- Hypoglycemia Unawareness Is Associated With Reduced Adherence to Therapeutic Decisions in Patients With Type 1 Diabetes: Evidence from a clinical audit
- (2009) C. B. Smith et al. DIABETES CARE
- Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE™ study
- (2009) M. Yenigun et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis
- (2008) M. Monami et al. DIABETES OBESITY & METABOLISM
- Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial
- (2008) P. C. Bartley et al. DIABETIC MEDICINE
- How hypoglycaemia can affect the life of a person with diabetes
- (2007) Brian M. Frier DIABETES-METABOLISM RESEARCH AND REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now